To demonstrate whether CCR5 inhibitors prevent HCC, we used a mouse model where the animals are exposed to a choline-deficient diet supplemented with ethionine in the drinking water (CDE) [28], [29]. Here, CCR5 is linked to hepatocellular carcinoma.